Brief: Biogen Is Said To Weigh Takeover Of $4 Billion Drugmaker Reata- Bloomberg News
28/07/2023 11:58
July 28 (Reuters) -
* BIOGEN IS SAID TO WEIGH TAKEOVER OF $4 BILLION DRUGMAKER
REATA-
BLOOMBERG NEWS
Source https://tinyurl.com/32tam4nt
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Reata Pharmaceuticals
See all newsReata Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Reata Pharmaceuticals Inc expected to post a loss of $2.88 a share - Earnings Preview
Brief: Biogen Inc Says If Deal Terminated Under Certain Conditions, Reata Will Be Required To Pay Biogen Termination Fee Equal To $264 Mln
U.S. STOCKS ON THE MOVE-US regional banks, Enphase, Centene
Biogen’s $7 bln deal goes smaller and safer